Document is current
Any future updates will be listed below
-
Authors
Vargas-Neri, Jessica Liliana https://orcid.org/0000-0002-8207-9407
Caro-Rojas, Angela https://orcid.org/0000-0001-9773-7188
Castañeda-Hernández, Gilberto https://orcid.org/0000-0001-9149-885X
Cuello-Meza, Christian Camilo
Duarte, Betty
Fontana, Daniela https://orcid.org/0009-0005-2517-8766
Galicia-Quintanar, Cinthya
Hall-Ramírez, Victoria https://orcid.org/0000-0003-4057-3930
Salas, Diego
Salas, Maribel https://orcid.org/0000-0001-5634-1558
Segura-Uribe, Julia Jeanett https://orcid.org/0000-0002-0676-5667
Tarapues, Mónica https://orcid.org/0000-0003-3959-0944
Zuluaga-Arias, Heyde Patricia https://orcid.org/0000-0003-1053-0454
Aceves-González, Carlos https://orcid.org/0000-0002-6720-808X
Bautista-Arteaga, Josué
Carreño-Quintero, William
Daza-Paz, Daniela
González-Achury, Diana María
Ramírez-Pedreros, Rosana Angélica
Galvis-Sánchez, Diego Armando https://orcid.org/0000-0001-5025-359X
Terán-Mercado, Luz Dary https://orcid.org/0009-0002-9139-4596
- License Information
-
More Information
Article History
Received: 16 October 2025
Accepted: 19 February 2026
First Online: 21 March 2026
Declarations
:
: GCH has received consultancy fees from Amgen, AbbVie, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sandoz, Sanofi, Servier, Takeda, and UCB. JBA collaborates (non-paid) with “Pharmacovigilance en Español” and works for Novartis as a GCP/GVP Auditor. DAGS is employed by a pharmaceutical company involved in biosimilars. The remaining authors have no conflicts of interest to declare.
: Not applicable. This study did not use personal data.
: Not applicable. This study did not involve human participants.
: Not applicable.
: Not applicable.
: Not applicable.
: JLVN, ACR, GCH, VHR, DF, and MS contributed to the conceptualization and design of the study. DAGS, DS, DMGA, WCQ, CCCM, JBA, LDTM, CAG, DDP, and RARP were responsible for data and information collection. JLVN, ACR, GCH, CCCM, BD, CGQ, VHR, DS, MS, and JJSU contributed to the original draft preparation. JLVN, GCH, CCCM, DF, VHR, JJSU, MT, HPZA, CAG, JBA, WCQ, DDP, DMGA, RARP, DAGS, and LDTM participated in the critical review and editing of the manuscript. All the authors read and approved the final version.
